When the COVID-19 pandemic forced our lab into quarantine, we repurposed a set of algorithms that we developed for cancer immunotherapy to the design of a COVID-19 vaccine. We will discuss the technologies that allow for algorithms that evaluate the immune response and their application to both cancer and vaccine development.